Cell Surface's 2026 Journal Metrics Score is 5.6, ranking Q1 in Plant Science and 2 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 6.47.
Middle 50%: 35–68 days
44 of 44 PubMed-indexed articles · 100% coverage · 2024–2025
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
28 of 86 works · same type, year & subfield
2 works · same type, year & subfield
Above field-year expectation
of 1,107 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.39, so its typical recent paper runs about 39% above its field benchmark.
32.6% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2017–2025
86 OpenAlex works · 2021–2024
OpenAlex topics show the research communities this journal serves.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Plant Science | Q1 |
| Infectious Diseases | Q1 |
| Epidemiology | Q1 |
Yes. A Q1 journal by citation data
Yes. By citation data, Cell Surface is a strong journal: it is Q1 in Plant Science and 2 other subfields and ranks #401 of 6,272 Medicine journals by Journal Metrics Score (top 7%). Cell Surface's 2026 Journal Metrics Score is 5.6. Recent papers took a median of 51 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $2,530 USD. OpenAlex classifies its papers in subfields including Plant Science, Infectious Diseases, and Epidemiology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
2026 Journal Metrics Scores for all 11 Cell journals published by Elsevier BV, highest score first. Each journal is scored separately; there is no combined score for the Cell family.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Cell Surface's papers in subfields including Plant Science, Infectious Diseases, and Epidemiology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Cell Surface homepage ↗Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage.
OpenAlex lists an indicative article processing charge of $2,530 USD for this open-access journal. Check the current fee, waivers, and any institutional agreement on the journal website.
Recent accepted papers took a median of 51 days from submission to acceptance, including revisions (PubMed dates). Cell Surface does not publish an acceptance rate.
Submission system from the publisher's author information, checked 2026-10-27. Individual journals can differ, so follow the link in the journal's own author guidelines.
New on PubMed
Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.
See a demo:GLP-1CRISPRLong COVID
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversYes. By citation data, Cell Surface is a strong journal: it is Q1 in Plant Science and 2 other subfields and ranks #401 of 6,272 Medicine journals by Journal Metrics Score (top 7%). Cell Surface's 2026 Journal Metrics Score is 5.6. Recent papers took a median of 51 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $2,530 USD. OpenAlex classifies its papers in subfields including Plant Science, Infectious Diseases, and Epidemiology, so check that your topic fits its scope.
Cell Surface's 2026 Journal Metrics Score is 5.6, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Cell Surface or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 51 days from submission to acceptance. To judge selectivity, compare Cell Surface's quartile and score with similar journals, or ask the editorial office.
Cell Surface's best quartile is Q1. By OpenAlex subfield: Q1 in Plant Science; Q1 in Infectious Diseases; Q1 in Epidemiology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Cell Surface will not match this score exactly. Compare journals using one source at a time.
Across 44 recent PubMed records with both dates, Cell Surface took a median of 51 days from submission to acceptance; the middle half took 35–68 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.
OpenAlex lists an indicative article processing charge of $2,530 USD for Cell Surface. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include Microbiological Research, Current Clinical Microbiology Reports, Mbio, and Mycology-An International Journal On Fungal Biology. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Most Elsevier and Cell Press journals take submissions through Editorial Manager; each journal has its own site, reached from Submit your article on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 51 days from submission to acceptance in recent PubMed records.